最新消息
News & Message
:::
Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilatorassociated pneumonia in intensive care units
Clinical characteristics and treatment outcomes among the hospitalized elderly patients with COVID-19 during the late pandemic phase in central Taiwan
High mortality of patients with severe pneumonia caused by respiratory syncytial virus, August 2021-June 2023, Taiwan
2025/2/3
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
作者群：鄭方茹(Cheng, Fang-Ju)、何建宜(Chien-Yi Ho)、李宗勳(Tzong Shiun Li)、陳曄(Yeh Chen)、葉屹倫(Yeh, Yi-Lun)、魏雅鈴(Ya-Ling Wei)、Huynh Kieu T(Huynh Kieu Thanh)、陳柏融(Chen, Bo-Rong)、(Hung Yu Ko)、薛晨希(Chen Si Hsueh)、譚明(Tan, Ming)、吳永昌(Yang-Chang Wu)、黃慧琪(Hui-Chi Huang)、湯智昕(Chih-Hsin Tang)、陳家弘(Chia-Hung Chen)、涂智彥(Chih-Yen Tu)、黃偉謙(Huang, Wei-Chien)*
期刊： Cell and Bioscience
出版年月：2023 Jun
相關文章
開關
首頁
Facebook
Instagram
體系醫院
中國醫點通